 |
|
The Comparative Efficacy of Colistin Monotherapy and Combination Therapy Based on in vitro Antimicrobial Synergy in Ventilator-associated Pneumonia Caused by Multi-drug Resistant Acinetobacter baumannii.
Hang Jea Jang, Mi Na Kim, Kwangha Lee, Sang Bum Hong, Chae Man Lim, Younsuck Koh
Tuberc Respir Dis. 2009;67(3):212-220. Published online 2009 Sep 1 DOI: https://doi.org/10.4046/trd.2009.67.3.212
|
|
Citations to this article as recorded by
 Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
Abdollah Ardebili, Ahdieh Izanloo, Mostafa Rastegar
Expert Review of Anti-infective Therapy.2023; 21(4): 387. CrossRef Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis
Shantanu K Patra, Samir Samal, Diganta Mohanty
Indian Journal of Critical Care Medicine.2021; 25(2): 199. CrossRef Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis
Hsiu-Ting Chien, Ying-Chi Lin, Chau-Chyun Sheu, Kun-Pin Hsieh, Jung-San Chang
International Journal of Antimicrobial Agents.2020; 55(3): 105889. CrossRef Clinical relevance of in vitro synergistic activity of antibiotics for multidrug-resistant Gram-negative infections: A systematic review
Konstantinos Z. Vardakas, Florentia Athanassaki, Vassiliki Pitiriga, Matthew E. Falagas
Journal of Global Antimicrobial Resistance.2019; 17: 250. CrossRef Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis
Jin Wang, Hui Niu, Rui Wang, Yun Cai
International Journal of Antimicrobial Agents.2019; 53(4): 383. CrossRef Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis
Konstantinos Z. Vardakas, Andreas D. Mavroudis, Maria Georgiou, Matthew E. Falagas
International Journal of Antimicrobial Agents.2018; 51(4): 535. CrossRef Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
Kirati Kengkla, Khachen Kongpakwattana, Surasak Saokaew, Anucha Apisarnthanarak, Nathorn Chaiyakunapruk
Journal of Antimicrobial Chemotherapy.2018; 73(1): 22. CrossRef Intravenous polymyxins: Revival with puzzle
Yun Yu, Aihua Fei, Zengbin Wu, Chengjin Gao, Shuming Pan
BioScience Trends.2017; 11(4): 370. CrossRef Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
Zhijin Chen, Yu Chen, Yaogao Fang, Xiaotian Wang, Yanqing Chen, Qingsong Qi, Fang Huang, Xungang Xiao
Scientific Reports.2015;[Epub] CrossRef Colistin for lung infection: an update
Mohan Gurjar
Journal of Intensive Care.2015; 3(1): 3. CrossRef Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: A systematic review and meta-analysis
Wan-Jie Gu, Fei Wang, Lu Tang, Jan Bakker, Jing-Chen Liu
International Journal of Antimicrobial Agents.2014; 44(6): 477. CrossRef Efficacy and Safety of Polymyxins for the Treatment of Acinectobacter baumannii Infection: A Systematic Review and Meta-Analysis
Qianqian Liu, Wenzhang Li, Yulin Feng, Chuanmin Tao, Shamala Devi Sekaran
PLoS ONE.2014; 9(6): e98091. CrossRef Clinical Characteristics in Patients with Carbapenem-ResistantAcinetobacter baumanniiIsolates from Tracheal Secretions
Jeong Ha Mok, Mi Hyun Kim, Kwangha Lee, Ki Uk Kim, Hye-Kyung Park, Min Ki Lee
Korean Journal of Critical Care Medicine.2013; 28(3): 173. CrossRef
|